Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
about
Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative CellsThe intestinal microbiome and surgical disease.The microbiota and immune response during Clostridium difficile infection.Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.Therapeutic manipulation of the microbiota: past, present, and considerations for the future.A genetic switch controls the production of flagella and toxins in Clostridium difficileSurviving Between Hosts: Sporulation and Transmission.The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile.Dipicolinic Acid Release by Germinating Clostridium difficile Spores Occurs through a Mechanosensing Mechanism.A Clostridium difficile-Specific, Gel-Forming Protein Required for Optimal Spore GerminationThe Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.Phase Variation of Clostridium difficile Virulence Factors.When pathogenic bacteria meet the intestinal microbiota.The esophageal microbiota in health and disease.The emerging metabolic view of Clostridium difficile pathogenesis.Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea.Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.Old and new models for studying host-microbe interactions in health and disease: C. difficile as an example.Disparate subcellular location of putative sortase substrates in Clostridium difficile.Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.Revisiting the role of Csp family proteins in regulating Clostridium difficile spore germination.Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced Clostridium difficile colitis.Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.A Clostridium difficile alanine racemase affects spore germination and accommodates serine as a substrate.Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile.Vaccines for Healthcare-associated Infections: Promise and Challenge.Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis.Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.The role of toxins in Clostridium difficile infection.Ethanolamine is a Valuable Nutrient Source that Impacts Clostridium difficile Pathogenesis.In silico analysis of antibiotic-induced Clostridium difficile infection: Remediation techniques and biological adaptations.Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection.Inactivation of Clostridium difficile spore outgrowth by synergistic effects of nisin and lysozyme.Beyond Structure: Defining the Function of the Gut Using Omic Approaches for Rational Design of Personalized Therapeutics.Understanding Clostridium difficile Colonization.Urinary Virome Perturbations in Kidney Transplantation.Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children.Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.Updates to Clostridium difficile Spore GerminationA comprehensive analysis of the faecal microbiome and metabolome of Strongyloides stercoralis infected volunteers from a non-endemic area
P2860
Q28821061-4CD667AE-088B-4F57-83C9-70C796C3EBB7Q30248605-76C2BA76-E2EF-4971-B538-9CD3B6630520Q30276756-A5BCD1D8-51D2-4E4E-9910-519CBC5A2BC1Q36013358-35D011F0-6409-4F4F-B78C-7BAC1D12FE04Q36130553-839722F7-B8D6-4B2F-BDF3-E3BDFEF8552FQ36323846-2B223D3F-A59C-4EF1-BD42-FFA99BDEAD5EQ37336501-C759EC53-F11E-415C-B1B7-C1776AA02151Q37424988-541387C3-038B-488C-B445-D18A46DA7C16Q37503755-651ED9A8-14D6-4B93-BC6A-CA65F78CD9AAQ37590711-D0086F0E-32E4-43D8-8981-1FD313C9879CQ37669836-3671F66F-3BF0-49EF-9A14-60DF2791461FQ38625957-7096E1AB-32B9-4E96-8645-28DD36E3D494Q38817334-DBAB772B-2472-48CA-8FC7-36A4E8216C0AQ38896455-EB3F5A86-4DB5-475D-B701-3FA312DF2E7CQ39044660-8AE20017-1411-4B45-8454-F32407EFC5BEQ39121926-4513D702-46B7-47B2-8E9E-9097C7B17877Q39197564-422C8664-178D-4004-939A-CC433727F36DQ39209496-101B3F92-C3DB-40FD-B4B2-12451AA670B9Q39347327-49F99318-6018-459C-8495-5EDBDD2E98BAQ39488475-0B852C91-FD29-4245-B9A3-A1506FDBFF2AQ40065922-2C2B4B42-FFEA-4A2A-8326-1ED751E04A3CQ40121761-A520E946-CD2F-4932-9717-0237E8F02929Q40125340-383A3891-F6A1-4AC5-A331-0488FD329880Q40219686-7C70781E-48CB-4F13-9331-554EBA05A4C9Q40324807-D80E9227-7E34-4651-95BD-9ACA56A47368Q40665389-75305255-D418-42E0-9657-DD0830382CD9Q45422950-4216A0CB-921E-461C-B9E0-06B5A536FC32Q47215602-4B788696-96FE-457A-8466-79CE56E84136Q47734724-EDB1D6C8-8421-44EB-ABC7-5849DDF49F73Q48210884-8968B544-A162-48D6-BFC3-33406B303256Q49925385-4D9072D2-055A-481F-BE9F-ABDF3D6034F5Q50016954-7CAFED97-C4D2-4750-A3B1-D9597F70EC6FQ51083862-C865C8B9-67E1-41CF-8500-BA8C7D778C6CQ52349483-3B734222-F117-483B-BB68-5FF54F75D326Q52802841-BB1B8D93-7319-46DE-88DD-1AF8F9C62BB5Q54978699-A7EB819C-66C3-4E68-917E-86F7596119ADQ55004309-032CDC20-72D8-41A1-AE79-063711C5E4A1Q55311464-BAB96562-8796-4F88-BD4C-63CDE332A379Q57114188-A05F8BCE-9F05-4BF4-A9A2-4413DD8C8473Q57799940-6D2EEB7B-41D4-4EEE-8A2A-8836A19888FA
P2860
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@ast
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@en
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@nl
type
label
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@ast
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@en
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@nl
prefLabel
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@ast
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@en
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@nl
P2860
P3181
P1476
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
@en
P2093
Casey M Theriot
Vincent B Young
P2860
P304
P3181
P356
10.1146/ANNUREV-MICRO-091014-104115
P407
P577
2015-01-01T00:00:00Z